Assignee profile:

GRUNENTHAL GMBH

City:

Aachen

Country:

Germany

Published Applications:

172

Last publication date:

2025-12-04

Patent Grants:

89

Last grant date:

2024-05-14

Top Inventors for applications by GRUNENTHAL GMBH

These are the the leading inventors for applications assigned to GRUNENTHAL GMBH:

Recent patent applications by GRUNENTHAL GMBH

GRUNENTHAL GMBH based in Aachen, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-12-04
US20250368625A1
Chemistry; metallurgy

PIPERAZINES

#2 | 2024-07-18
US20240238221A1
Human necessities

TAPENTADOL FOR TREATING NEUROPATHIC PAIN IN COVID-19 PATIENTS

#3 | 2023-09-28
US20230303573A1
Chemistry; metallurgy

3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#4 | 2021-08-26
US20210261492A1
Chemistry; metallurgy

CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDE

#5 | 2021-07-15
US20210214315A1
Chemistry; metallurgy

3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#6 | 2021-06-24
US20210188860A1
Chemistry; metallurgy

3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#7 | 2021-06-17
US20210179627A1
Chemistry; metallurgy

3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#8 | 2021-06-17
US20210179595A1
Chemistry; metallurgy

8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#9 | 2021-06-17
US20210179592A1
Chemistry; metallurgy

3-((HETERO-)ARYL)-ALKYL-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES

#10 | 2021-06-03 ✅ Patent 11,981,677 granted on 2024-05-14
US20210163491A1
Chemistry; metallurgy

Further substituted triazolo quinoxaline derivatives

#11 | 2021-05-06 ✅ Patent 11,739,049 granted on 2023-08-29
US20210130282A1
Chemistry; metallurgy

Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol

#12 | 2021-02-04
US20210032256A1
Chemistry; metallurgy

3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#13 | 2020-12-24
US20200399280A1
Chemistry; metallurgy

3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#14 | 2020-12-24
US20200399255A1
Chemistry; metallurgy

8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#15 | 2020-12-24
US20200399252A1
Chemistry; metallurgy

3-((HETERO-)ARYL)-ALKYL-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES

#16 | 2020-12-24
US20200399226A1
Chemistry; metallurgy

3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#17 | 2020-12-24 ✅ Patent 11,844,865 granted on 2023-12-19
US20200397704A1
Human necessities

Abuse-proofed oral dosage form

#18 | 2020-12-10
US20200385334A1
Chemistry; metallurgy

CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDE

#19 | 2020-10-22
US20200331864A1
Chemistry; metallurgy

1,3-DIAZA-SPIRO-[3.4]-OCTANE DERIVATIVES

#20 | 2020-09-24
US20200299225A1
Chemistry; metallurgy

PROCESS FOR THE PREPARATION OF (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL

#21 | 2020-09-03
US20200276188A1
Human necessities

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

#22 | 2020-08-27
US20200268748A1
Human necessities

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

#23 | 2020-04-02
US20200102261A1
Chemistry; metallurgy

CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDE

#24 | 2020-01-23 ✅ Patent 10,981,918 granted on 2021-04-20
US20200024281A1
Chemistry; metallurgy

Further substituted triazolo quinoxaline derivatives

#25 | 2020-01-09 ✅ Patent 10,813,891 granted on 2020-10-27
US20200009083A1
Human necessities

Method of inhibiting chronification of pain

#26 | 2019-12-19 ✅ Patent 10,807,989 granted on 2020-10-20
US20190382407A1
Chemistry; metallurgy

3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives

#27 | 2019-12-12 ✅ Patent 10,807,988 granted on 2020-10-20
US20190375754A1
Chemistry; metallurgy

3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives

#28 | 2019-12-12 ✅ Patent 10,793,556 granted on 2020-10-06
US20190375738A1
Chemistry; metallurgy

8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives

#29 | 2019-12-12 ✅ Patent 10,793,528 granted on 2020-10-06
US20190375718A1
Chemistry; metallurgy

3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives

#30 | 2019-09-26 ✅ Patent 11,344,512 granted on 2022-05-31
US20190290603A1
Human necessities

Titration of tapentadol

#31 | 2019-09-05 ✅ Patent 10,695,297 granted on 2020-06-30
US20190269621A1
Human necessities

Tamper-resistant tablet providing immediate drug release

#32 | 2019-08-29
US20190263747A1
Chemistry; metallurgy

PROCESS FOR THE PREPARATION OF (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL

#33 | 2019-08-15 ✅ Patent 10,576,047 granted on 2020-03-03
US20190247336A1
Human necessities

Formulations for the treatment of pain

#34 | 2019-08-15
US20190247332A1
Human necessities

TAMPER RESISTANT FORMULATION OF EPHEDRINE AND ITS DERIVATIVES COMPRISING A CONVERSION INHIBITOR

#35 | 2019-05-16 ✅ Patent 10,526,358 granted on 2020-01-07
US20190144474A1
Chemistry; metallurgy

Crystalline forms

#36 | 2019-05-16
US20190142767A1
Human necessities

ABUSE-PROOFED ORAL DOSAGE FORM

#37 | 2019-05-02 ✅ Patent 10,864,164 granted on 2020-12-15
US20190125680A1
Human necessities

Tamper-resistant tablet providing immediate drug release

#38 | 2019-04-18
US20190110992A1
Human necessities

MODIFIED RELEASE ABUSE DETERRENT DOSAGE FORMS

#39 | 2019-03-21
US20190083407A1
Human necessities

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

#40 | 2019-01-03 ✅ Patent 10,519,176 granted on 2019-12-31
US20190002483A1
Chemistry; metallurgy

Crystalline forms

#41 | 2018-12-27
US20180369149A1
Human necessities

Tamper-resistant tablet providing immediate drug release

#42 | 2018-11-22 ✅ Patent 10,323,052 granted on 2019-06-18
US20180333425A1
Human necessities

Crystallization method and bioavailability

#43 | 2018-08-30
US20180243237A1
Human necessities

ABUSE-PROOFED DOSAGE FORM

#44 | 2018-06-21 ✅ Patent 10,653,647 granted on 2020-05-19
US20180169039A1
Human necessities

Methods and compositions for administration of TRPV1 agonists

#45 | 2018-05-10 ✅ Patent 11,013,701 granted on 2021-05-25
US20180125800A1
Human necessities

Stable formulation for parenteral administration of tapentadol

#46 | 2018-02-15
US20180044348A1
Chemistry; metallurgy

CRYSTALLINE SALTS OF MORPHINE SULFATE

#47 | 2018-02-01
US20180028670A1
Human necessities

TAMPER RESISTANT DOSAGE FORM COMPRISING AN ANIONIC POLYSACCHARIDE

#48 | 2017-11-23 ✅ Patent 10,813,890 granted on 2020-10-27
US20170333369A1
Human necessities

Pharmaceutical combination

#49 | 2017-11-02
US20170312271A1
Human necessities

CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS

#50 | 2017-05-04
US20170119663A1
Human necessities

NOVEL GASTRO-RETENTIVE DOSAGE FORMS

#51 | 2017-02-23
US20170049706A1
Human necessities

PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED DOSAGE FORM

#52 | 2016-12-15 ✅ Patent 10,912,763 granted on 2021-02-09
US20160361294A1
Human necessities

Pharmaceutical dosage forms comprising 6′-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine

#53 | 2016-10-27 ✅ Patent 9,855,263 granted on 2018-01-02
US20160310487A1
Human necessities

Tamper-resistant dosage form with immediate release and resistance against solvent extraction

#54 | 2016-10-27
US20160310428A1
Human necessities

TAMPER-RESISTANT FIXED DOSE COMBINATION PROVIDING FAST RELEASE OF TWO DRUGS FROM DIFFERENT PARTICLES

#55 | 2016-09-15 ✅ Patent 10,449,547 granted on 2019-10-22
US20160263032A1
Human necessities

Preparation of a powdery pharmaceutical composition by means of cryo-milling

#56 | 2016-07-14
US20160199306A1
Human necessities

Tamper-resistant tablet providing immediate drug release

#57 | 2016-05-05
US20160120810A1
Human necessities

CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS

#58 | 2016-04-21 ✅ Patent 10,300,141 granted on 2019-05-28
US20160106839A1
Human necessities

Tamper resistant dosage form comprising inorganic salt

#59 | 2015-10-29 ✅ Patent 9,725,459 granted on 2017-08-08
US20150307507A1
Chemistry; metallurgy

3-oxo-tetrahydro-furo[3,2-B]pyrrol-4(5H)-yl) derivatives I

#60 | 2014-10-30
US20140322311A1
Human necessities

CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM

#61 | 2014-07-31 ✅ Patent 9,278,103 granted on 2016-03-08
US20140213569A1
Human necessities

Substituted 6-amino-nicotinamides as KCNQ2/3 modulators

#62 | 2014-07-10
US20140194455A1
Human necessities

OXIDATION-STABILIZED TAMPER-RESISTANT DOSAGE FORM

#63 | 2014-07-10 ✅ Patent 9,078,899 granted on 2015-07-14
US20140194452A1
Human necessities

Pyrazolyl-based carboxamides II

#64 | 2014-07-10 ✅ Patent 9,206,136 granted on 2015-12-08
US20140194443A1
Human necessities

Pyrazolyl-based carboxamides I

#65 | 2014-06-05
US20140155489A1
Human necessities

PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED SOLID DOSAGE FORM

#66 | 2014-04-03
US20140093559A1
Human necessities

ABUSE-PROOFED DOSAGE FORM

#67 | 2014-03-27 ✅ Patent 8,969,368 granted on 2015-03-03
US20140088132A1
Chemistry; metallurgy

Crystalline, anhydrous forms of oxymorphone hydrochloride

#68 | 2014-03-27
US20140086847A1
Human necessities

DOSAGE FORM THAT IS SAFEGUARDED FROM ABUSE

#69 | 2014-03-20 ✅ Patent 9,073,862 granted on 2015-07-07
US20140080867A1
Chemistry; metallurgy

Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators

#70 | 2013-10-24 ✅ Patent 10,335,373 granted on 2019-07-02
US20130280338A1
Human necessities

Tamper resistant and dose-dumping resistant pharmaceutical dosage form

#71 | 2013-08-29
US20130225697A1
Human necessities

TAMPER-RESISTANT DOSAGE FORM COMPRISING PHARMACOLOGICALLY ACTIVE COMPOUND AND ANIONIC POLYMER

#72 | 2013-08-29
US20130225625A1
Human necessities

TAMPER-RESISTANT PHARMACEUTICAL DOSAGE FORM COMPRISING NONIONIC SURFACTANT

#73 | 2013-08-15
US20130209557A1
Human necessities

TAMPER RESISTANT DOSAGE FORM COMPRISING INORGANIC SALT

#74 | 2013-08-01 ✅ Patent 9,403,767 granted on 2016-08-02
US20130197095A1
Chemistry; metallurgy

Substituted 4-aminocyclohexane derivatives

#75 | 2013-08-01
US20130195935A1
Human necessities

ABUSE-PROOFED DOSAGE FORM

#76 | 2013-07-04
US20130171075A1
Human necessities

ABUSE-PROOFED DOSAGE FORM

#77 | 2013-06-06 ✅ Patent 9,234,630 granted on 2016-01-12
US20130139894A1
Mechanical engineering

Method and device for supplying liquids to analysis units and liquid handling systems

#78 | 2013-04-11
US20130090349A1
Human necessities

Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist

#79 | 2013-03-07 ✅ Patent 8,704,002 granted on 2014-04-22
US20130060065A1
Chemistry; metallurgy

Process for the dehydration of substituted 4-dimethylamino-2-aryl-butan-2-ol compounds and process for the preparation of substituted dimethyl-(3-aryl-butyl)-amine compounds by heterogeneous catalysis

#80 | 2013-01-31
US20130028972A1
Human necessities

Tamper-resistant tablet providing immediate drug release

#81 | 2013-01-31 ✅ Patent 10,201,502 granted on 2019-02-12
US20130028970A1
Human necessities

Tamper-resistant tablet providing immediate drug release

#82 | 2012-12-06
US20120308654A1
Human necessities

ABUSE-PROOFED DOSAGE FORM

#83 | 2012-10-11 ✅ Patent 9,168,259 granted on 2015-10-27
US20120258947A1
Human necessities

Substituted 6-amino-nicotinamides as KCNQ2/3 modulators

#84 | 2012-08-30 ✅ Patent 8,470,852 granted on 2013-06-25
US20120220627A1
Chemistry; metallurgy

Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators

#85 | 2012-08-09 ✅ Patent 8,835,689 granted on 2014-09-16
US20120202810A1
Chemistry; metallurgy

Substituted 4-aminocyclohexane derivatives

#86 | 2012-07-19 ✅ Patent 8,586,755 granted on 2013-11-19
US20120184550A1
Chemistry; metallurgy

Substituted nicotinamides as KCNQ2/3 modulators

#87 | 2012-05-31
US20120136021A1
Human necessities

OXIDATION-STABILIZED TAMPER-RESISTANT DOSAGE FORM

#88 | 2012-05-31
US20120135071A1
Human necessities

Abuse-proofed dosage form

#89 | 2012-05-03 ✅ Patent 8,309,060 granted on 2012-11-13
US20120107250A1
Human necessities

Abuse-proofed dosage form

#90 | 2012-04-26 ✅ Patent 8,552,200 granted on 2013-10-08
US20120101079A1
Chemistry; metallurgy

Substituted 6-amino-nicotinamides as KCNQ2/3 modulators

#91 | 2012-03-15 ✅ Patent 9,636,303 granted on 2017-05-02
US20120065220A1
Human necessities

Tamper resistant dosage form comprising an anionic polymer

#92 | 2012-03-08 ✅ Patent 10,160,719 granted on 2018-12-25
US20120059066A1
Chemistry; metallurgy

Pharmaceutical salts

#93 | 2012-03-08
US20120059065A1
Human necessities

Tamper Resistant Dosage Form Comprising An Anionic Polymer

#94 | 2012-03-01 ✅ Patent 8,653,102 granted on 2014-02-18
US20120053206A1
Chemistry; metallurgy

Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators

#95 | 2012-03-01 ✅ Patent 8,653,101 granted on 2014-02-18
US20120053205A1
Chemistry; metallurgy

Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators

#96 | 2012-03-01 ✅ Patent 8,445,512 granted on 2013-05-21
US20120053204A1
Chemistry; metallurgy

Substituted quinoline-3-carboxamides as KCNQ2/3 modulators

#97 | 2012-03-01 ✅ Patent 8,618,129 granted on 2013-12-31
US20120053203A1
Chemistry; metallurgy

Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators

#98 | 2012-02-23
US20120046272A1
Chemistry; metallurgy

Novel Therapeutic Compounds

#99 | 2012-02-09 ✅ Patent 8,420,056 granted on 2013-04-16
US20120034171A1
Human necessities

Abuse-proofed dosage form

#100 | 2012-02-02
US20120028936A1
Human necessities

ORAL CONTRACEPTION WITH TRIMEGESTONE

Also check out Grünenthal GmbH's (Aachen, Germany) applicant profile with 33 patent applications submitted.

AssigneeID:

7125 ⎘